摘要
目的评估布地奈德联合特布他林吸入治疗咳嗽变异性哮喘的临床效果。方法将76例咳嗽变异性哮喘患者随机分为两组,对照组38例单用特布他林吸入治疗,观察组38例采取布地奈德联合特布他林吸入治疗。结果观察组治愈率(89.47%)高于对照组(63.16%),两组数据差异有统计学意义(P<0.05)。观察组患者慢性咳嗽消退时间短于对照组(P<0.05)。结论咳嗽变异性哮喘采取布地奈德联合特布他林吸入治疗效果较好。
Objective Evaluation effect of budesonide Combined terbutaline inhalation in treatment of cough variant asthma. Methods 76 cases of cough variant asthma patients were randomly divided into 2 groups, control group of 38 cases of terbutaline inhalation therapy, observation group 38 cases take budesonide Combined terbutaline treatment. Results Observation group cure rate（89.47%） is significantly higher than the control group（63.16%）, two groups of data difference was statistically significant（P〈0.05）. Observation group of patients with chronic cough fade time was significantly shorter than the control group（P〈0.05）. Conclusion Cough variant asthma to budesonide Combined terbutaline treatment, the effect is remarkable.
出处
《中国继续医学教育》
2015年第32期163-164,共2页
China Continuing Medical Education
